Cargando…

Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

PURPOSE: This study explored the value of the serum creatinine/cystatin C (Cr/CysC) ratio in diagnosing the reduction of muscle strength in men with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). PATIENTS AND METHODS: In this study, we enrolled 72 male patients with AECOPD and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Dan, Xie, Canhui, Sun, Chaoqun, Chen, Min, Li, Lian, Yi, Huajuan, Liao, Jinyu, Zhao, Xuanna, Shen, Xiaoping, He, Donglan, Li, Dongming, Wu, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004674/ https://www.ncbi.nlm.nih.gov/pubmed/35422619 http://dx.doi.org/10.2147/COPD.S356314

Ejemplares similares

The serum creatinine to cystatin C ratio predicts the risk of acute exacerbation of chronic obstructive pulmonary disease
por: He, Liang, et al.
Publicado: (2023)

Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Chen, Zhixiang, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults
por: Tan, Lingling, et al.
Publicado: (2020)

Association Between Thyroid Function and Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Huang, Dan, et al.
Publicado: (2021)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury
por: İnal, Salih, et al.
Publicado: (2014)

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
por: Jung, Chan‐Young, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
por: Gao, Shunhui, et al.
Publicado: (2023)

Serum-Creatinine-to-Cystatin C-to-Waist-Circumference Ratios as an Indicator of Severe Airflow Limitation in Older Adults
por: Li, Jinxuan, et al.
Publicado: (2023)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
por: Zhu, Yueli, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
por: Sun, Jing, et al.
Publicado: (2022)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Association of serum creatinine-to-cystatin C ratio with skeletal muscle mass and strength in nonalcoholic fatty liver disease in the Iwaki Health Promotion Project
por: Mikami, Kenichiro, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
por: Zheng, Chao, et al.
Publicado: (2022)

Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study
por: Wei, Wen, et al.
Publicado: (2022)

Creatinine and cystatin C: Shooting at a flying target
por: Chao, Chia-Ter
Publicado: (2011)

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
por: Fujita, Kohei, et al.
Publicado: (2022)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
por: Hyun, Young Youl, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
por: Ding, Ping’an, et al.
Publicado: (2022)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
por: An, Jung Nam, et al.
Publicado: (2022)

The Utility of the Creatinine Excretion to Production Ratio and the Plasma Creatinine and Cystatin C Based Kinetic Estimates of Glomerular Filtration Rates in Critically Ill Patients with Sepsis
por: Md Ralib, Azrina, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio is a predictor of all-cause mortality for older adults over 80 years
por: Zhang, Li, et al.
Publicado: (2023)

Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
por: Shi, Shanshan, et al.
Publicado: (2022)

The Ratio of Estimated Glomerular Filtration Rate Based on Cystatin C and Creatinine Reflecting Cardiovascular Risk in Diabetic Patients
por: Khang, Ah Reum, et al.
Publicado: (2023)

Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
por: Yoshii, Ichiro, et al.
Publicado: (2023)

Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2023)

Spot Urine Albumin to Creatinine Ratio and Serum Cystatin C are Effective for Detection of Diabetic Nephropathy in Childhood Diabetic Patients
por: Chae, Hyun-Wook, et al.
Publicado: (2012)

Serum creatinine to cystatin C ratio reflects preoperative and early postoperative walking ability in older patients with hip fracture
por: Okubo, Naoki, et al.
Publicado: (2022)

Changes in Mortality According to Creatinine/Cystatin C Ratio in Chronic Kidney Disease and Non-chronic Kidney Disease Patients
por: Hwang, Jeong Ah, et al.
Publicado: (2022)

Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifan, et al.
Publicado: (2022)

Predictive value of serum creatinine/cystatin C in neurocritically ill patients
por: Wang, Shengnan, et al.
Publicado: (2019)

Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C
por: Screever, Elles M., et al.
Publicado: (2021)

Muscle mass, creatinine, cystatin C and selective glomerular hypofiltration syndromes
por: Malmgren, Linnea, et al.
Publicado: (2023)

Independent associations of urinary albumin-to-creatinine ratio and serum cystatin C with carotid intima-media thickness in community-living Taiwanese adults
por: Liu, Chiu-Shong, et al.
Publicado: (2020)

Age- and sex-specific reference intervals for the serum cystatin C/creatinine ratio in healthy children (0–18 years old)
por: Liu, Changjin, et al.
Publicado: (2019)

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifang, et al.
Publicado: (2022)

Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study
por: Qiu, Shanhu, et al.
Publicado: (2022)

The serum creatinine to cystatin C to waist circumference ratios predicts risk for type 2 diabetes: A Chinese cohort study
por: Chen, Yinfei, et al.
Publicado: (2023)

A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD
por: Lin, Yu-Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ig62ek0uh9fbprrd5ijvv0p2l